Danish drugmaker Novo Nordisk's stock was down nearly 20% in premarket trading Tuesday morning after the company cut its ...

Drugmaker struggled to adapt to very high demand and a market where celebrities are more influential than doctors ...

The explosive popularity of GLP-1 weight-loss medications such as Ozempic®, Wegovy®, and Mounjaro® has transformed obesity care and created an unexpected cosmetic challenge. Rapid fat loss can leave ...

What happens when you stop taking Ozempic®? There’s no one-size-fits-all answer to this question. When you stop taking ...

New research shows that most people regain weight after stopping Ozempic and similar weight-loss drugs around the eight-week ...

The overarching commonality is that there isn't one: "Not all people experiences the same degree of facial and body changes ...

GLP-1 drugs like semaglutide (Ozempic) and tirzepatide (Mounjaro) may shrink fat, but also crucial muscle mass, with little ...

There’s lots of misinformation about Ozempic for weight loss on social media, and there are a few safety concerns you need to know about. But the drug can help you lose weight — if it’s a ...

Investors knocked $70bn off Novo Nordisk’s market value on Tuesday after the maker of weight-loss drug Wegovy issued a profit warning and named a new CEO, as it battles rising competition in the ...

Powerful new medications such as Ozempic and Mounjaro, known as GLP-1 drugs are helping to win the war against obesity in ...

Discover effective weight loss strategies from Snigdha Baruah, who lost 35 kg without shortcuts, Ozempic, or extreme workouts ...

Both Ozempic and Mounjaro are approved by the U.S. Food and Drug Administration to treat Type 2 diabetes, but some doctors prescribe the medication "off-label" for weight loss, as is permissible ...